Figure 9
The relationships between low/high-risk groups and chemotherapeutics. Drugs testing is assessed by IC50, such as Axitinib, Docetaxel, Embelin, Epothilone.B, Parthenolide, Thapsigargin, Tipifarnib, Vinorelbine.
Figure 9 | Scientific Reports
The relationships between low/high-risk groups and chemotherapeutics. Drugs testing is assessed by IC50, such as Axitinib, Docetaxel, Embelin, Epothilone.B, Parthenolide, Thapsigargin, Tipifarnib, Vinorelbine.
